Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A(4) analog: Protective mechanisms and long‐term effects on neurological recovery

BACKGROUND: Resolution of inflammation is an emerging new strategy to reduce damage following ischemic stroke. Lipoxin A(4) (LXA (4)) is an anti‐inflammatory, pro‐resolution lipid mediator that reduces neuroinflammation in stroke. Since LXA (4) is rapidly inactivated, potent analogs have been synthe...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Brain Behav
Glavni autori: Hawkins, Kimberly E., DeMars, Kelly M., Alexander, Jon C., de Leon, Lauren G., Pacheco, Sean C., Graves, Christina, Yang, Changjun, McCrea, Austin O., Frankowski, Jan C., Garrett, Timothy J., Febo, Marcelo, Candelario‐Jalil, Eduardo
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2017
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5434193/
https://ncbi.nlm.nih.gov/pubmed/28523230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.688
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items